Clinical trials
Recruiting Triple Negative Breast Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Gilead Sciences | 1 |
| Jules Bordet Institute | 1 |
| Maastricht University Medical Center | 1 |
| Novartis Pharmaceuticals | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| UNICANCER | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 12 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Fallopian Tube Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.